Target intelligence / Profile preview

RNA, U6 small nuclear 526, pseudogene (RNU6-526P)

Target
RNU6-526P
Molecular classification
Pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 526, pseudogene (RNU6-526P) is a processed pseudogene related to the **U6 small nuclear RNA (snRNA)** gene family[1]. The canonical U6 snRNA is a highly conserved, non-coding RNA essential for the spliceosome, the complex responsible for mRNA splicing in eukaryotes; however, **RNU6-526P does not produce a functional RNA molecule** and has no known biological activity[1][2][3]. U6 snRNA pseudogenes—including RNU6-526P—are typically produced by retrotransposition processes, often mediated by LINE-1 elements, resulting in genomic insertions that lack the regulatory elements or sequence integrity necessary for function[2][3]. Such pseudogenes are usually classified as "processed" because they are copied from RNA intermediates and do not contain introns. While the active U6 snRNA is fundamental for RNA processing, its pseudogenes serve primarily as genomic fossils, and are sometimes used as evolutionary or retrotransposition markers but not as therapeutic targets[2][3]. Key points: - **RNU6-526P is not an active gene or therapeutic target**; it is a **pseudogene**. - It does **not code for a protein** or functional RNA, and there are **no drugs or direct disease links** associated with this pseudogene[1][2][3]. - The only legitimate function of such pseudogenes is in **genomic studies and evolutionary biology**, not in pharmacology or disease targeting[2][3].

Other names
RNU6-526P
02

Biological functions

No known biological function as a pseudogeneDoes not encode a functional product[1][2]
03

Disease associations

Other (Pseudogenes generally do not have established direct roles in disease, although they can act as markers in some contexts[2])

Beyond the preview

Go deeper on RNA, U6 small nuclear 526, pseudogene (RNU6-526P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 526, pseudogene (RNU6-526P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call